Delivery Order SPE2DB22D2214-SPE2DB25FS5PB
Award Date
6/26/25
Potential Completion Date
7/18/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,491.97 firm-fixed-price contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of July 24, 2025. The contract is not set aside and appears to be part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $13,491.97 and a period of performance through May 16, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $13,491.97 and a completion date of June 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a $25,121.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. The company has been...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a firm fixed price of $13,491.97 and a performance period through June 30, 2025. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FC0C0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,491.97 firm fixed-price delivery order is for the supply of 4,568,075,826 units of the drug LUMAKRAS 320 MG TABLET 90S. The contract has a completion date of May 20, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award is for the delivery of Lumakras 120 mg tablets to the Defense Logistics Agency (DLA). The $24,084.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 22, 2023. The contract has a completion date of March 15, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,446.16 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a medical product, with a completion date of July 10, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KRAZATI 200 MG TABLET 180S, a medical product, with a ceiling value of $12,629.53 and a period of performance through July 9, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Mekinist 0.5 mg tablet. The contract has a firm fixed price of $8,552.49 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...